Pouya Motazedian

Cardiology Resident | University of Ottawa Heart Institute

[Benjamin Hibbert @benhibbertMDPhD]

#VTstorm is a common problem in #CICU #critcarecardio. SGB is purported to be a treatment for this condition. @_profmota reports in @SciReports @NaturePortfolio an overview of data supporting this strategy.
https://t.co/FGvvznOFe5 for the open access PDF

[Benjamin Hibbert @benhibbertMDPhD]

How can we improve #POCUS utility and democratize application - #AI augmentation! Both senior and novice scanners can rapidly and accurately measure and classify LVEF across clinical settings (echo lab, ward, ED, ICU).

[American College of Cardiology @ACCinTouch]

Pulmonary vein stenosis can arise from several etiologies, including congenital, acquired & iatrogenic sources. PVS presents insidiously, leading to significant delays in diagnosis. Read more on PVS in #JACC: https://t.co/OeDTSMBqDj

[Jeffrey Marbach @JAMarbach]

The five year follow up https://t.co/LzsXmreQwZ to our initial publication on the impact of a formal research curriculum in cardiology training https://t.co/7ad8j2clCz @tjsimard @benhibbertMDPhD @JCigarroaMD

[Trevor Simard @tjsimard]

Our report on a rabbit model for evaluation of stent healing using optical coherence tomography (OCT). Several observations to help guide pragmatic translational study design. Great work by the team to bring this analysis of >1,000 stent segments together. https://t.co/5X5r95ApEh

[Simon Parlow @sdparlow]

Introducing CAPITAL DOREMI2: a follow-up to the DOREMI trial published in NEJM. This is a randomized clinical trial comparing inotrope therapy to placebo in the initial 12-hour resuscitation of patients with SCAI C or D cardiogenic shock https://t.co/eihGuFr9EH